August 31, 2015
By Mark Terry, BioSpace.com Breaking News Staff
Paris-based Sanofi (SNY) announced today that it will partner with Google /Alphabet’s Life Sciences on diabetes monitoring and treatment. No financial details were disclosed.
“As a global leader in diabetes care, we have both an obligation and a commitment to provide integrated solutions for people living with diabetes,” said Olivier Brandicourt, chief executive officer of Sanofi in a statement. “This initiative combines Sanofi’s strength and knowledge in diabetes with Google Inc.’s leadership in technology and analytics to create a first-of-its-kind initiative with the potential to transform diabetes care.”
Google, which recently announced that it was forming an umbrella holding company, Alphabet, and spinning off various companies, including Life Sciences, announced on Aug. 20, 2015 that the first company to stand alone under Alphabet was Life Sciences. Life Sciences is developing contact lenses that can monitor blood sugar levels with Alcon Laboratories, Inc. (ACL), a division of Novartis (NVS). It also has a 10-year collaboration deal with Chicago-based AbbVie (ABBV) to study age-related diseases.